HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

TKALTEVIPLTEEAELEL Pol(441-458) human epitope
      VIPLTEEAE Pol(447-455) human epitope
      LVKHHLTEEAELELA Pol(447-459) human epitope
       IPLTEEAEL Pol(448-456) B*07:02, B*35:01, B*51:01, B*53:01 human epitope
       IPLTEEAEL Pol(448-456) B*15:01, B*35:01 human epitope
       IPLTEEAEL Pol(448-456) B*35 epitope
       IPLTEEAEL Pol(448-456) B*35 human epitope
       IPLTEEAEL Pol(448-456) B35 human epitope
       IPLTEEAEL Pol(448-456) B35 human epitope
       IPLTEEAEL Pol(448-456) B35 human epitope
       IPLTEEAEL Pol(448-456) B35 human epitope
       IPLTEEAEL Pol(448-456) B35, B51 human epitope
       IPLTEEAEL Pol(448-456) B*35:01 human epitope
       IPLTEEAEL Pol(448-456) B*35:01 human epitope
       IPLTEEAEL Pol(448-456) B*35:01 human epitope
       IPLTEEAEL Pol(448-456) B*35:01, B*51:01 human epitope
       IPLTEEAEL Pol(448-456) B*35:01, B*51:01 human epitope
       IPLTEEAEL Pol(448-456) B51 human epitope
       IPLTEEAEL Pol(448-456) B51 human epitope
       VPLTREAEL Pol(448-456) B51 human epitope
       IPLTEEAEL Pol(448-456) B7 human epitope
       IPLTEaAEL Pol(448-456) diminished response
       IPLTEEAgL Pol(448-456) observed variant
       IPLTEEAgf Pol(448-456) diminished response
       IPLTgEAEL Pol(448-456) diminished response
       IPLTqEAEL Pol(448-456) diminished response
       IPLTvEAEL Pol(448-456) diminished response
       IPLTaEAEL Pol(448-456) diminished response
       VPLTAEAEM Pol(448-456) human epitope
       IPLTEEAEL Pol(448-456) human epitope
       VPLTEEAEL Pol(448-456) human epitope
       VPLTkEAEL Pol(448-456) replicative capacity is not abrogated
       IPLTEEAEL Pol(448-456) human epitope
       IPLTEEAEL Pol(448-456) human epitope
        H+LTEEAELELAENRE Pol(449-463) human epitope
        PLTEEAELELAENREILKEPVHGVY Pol(449-473) A2 human epitope
         LTEEAELEL Pol(450-458) human epitope
            EAELELAENREILKE Pol(453-467) human epitope
            aAELELAENREILKE Pol(453-467) observed variant
            EAgfELAENREILKE Pol(453-467) observed variant
            EAgLELAENREILKE Pol(453-467) observed variant
            EAELELAENREILeE Pol(453-467) observed variant
            EAELELAgNREILKE Pol(453-467) observed variant
                ELAENREILKEPVHGVYY Pol(457-474) C*01, C*02 human epitope
                ELAENREILKEPVHGVYY Pol(457-474) C*02:02 human epitope
                ELAENREILKEPVHGVYY Pol(457-474) human epitope
                  AENREILKE Pol(459-467) human epitope
                   KNREILKDPVHGVYYD Pol(460-475) human epitope
                      EILKEPVHGV Pol(463-472) A*02:01 humanized mouse epitope
                      EILKEPVGHV Pol(463-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILqEPVHGV Pol(464-472) observed variant
                       ILKEPVHGa Pol(464-472) observed variant
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILRIPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 transgenic mouse epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human, transgenic mouse epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 humanized mouse epitope
                       ILKEPVHGV Pol(464-472) A*02:01 mouse epitope
                       ILKEPVHGV Pol(464-472) A*02:01 mouse epitope
                       ILKEPVHGV Pol(464-472) A*02:01 transgenic mouse epitope
                       ILKEPVHGV Pol(464-472) A*02:01 mouse epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human, macaque epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 transgenic mouse epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 humanized mouse epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGa Pol(464-472) inferred escape
                       ILKEPiHGa Pol(464-472) inferred escape
                       ILrEPVHGV Pol(464-472) inferred escape
                       ILKEPVHea Pol(464-472) inferred escape
                       ILKgPVHGa Pol(464-472) inferred escape
                       ILeEPVHGa Pol(464-472) inferred escape
                       ILrEPVHGa Pol(464-472) inferred escape
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 humanized mouse epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 transgenic mouse epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01 human epitope
                       ILKDPVHGV Pol(464-472) A*02:01 humanized mouse epitope
                       ILKEPVHGV Pol(464-472) A*02:01, A*02:05 human epitope
                       ILKEPVHGV Pol(464-472) A*02:01, A2 human epitope
                       ILKEPVHGV Pol(464-472) A*02:02, A2 human epitope
                       ILKdPVHGV Pol(464-472) susceptible form
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 mouse epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 transgenic mouse epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 transgenic mouse epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILRIPVHGV Pol(464-472) A2 human epitope
                       ILKDPVHGV Pol(464-472) A2 human epitope
                       ILKePVHGV Pol(464-472) susceptible form
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKdPVHGV Pol(464-472) diminished response
                       ILKdPVHeV Pol(464-472) diminished response
                       yLKEPVHGV Pol(464-472) susceptible form
                       fLKEPVHGV Pol(464-472) susceptible form
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 transgenic mouse epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human, transgenic mouse epitope
                       ILKDPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHeV Pol(464-472) susceptible form
                       ILKdPVHGV Pol(464-472) non-susceptible form
                       ILKEPVHGV Pol(464-472) A2 epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKElVHGV Pol(464-472) escape documented in this paper
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 transgenic mouse epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 mouse epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKdPVHGV Pol(464-472) subtype-specific non-susceptible form
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGa Pol(464-472) observed variant
                       IiKEPVHxx Pol(464-472) observed variant
                       ILKDPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKEPVHGV Pol(464-472) A2 human, transgenic mouse epitope
                       ILKdPVHGV Pol(464-472) diminished response
                       ILKEPVHrV Pol(464-472) susceptible form
                       ILrEPiHGV Pol(464-472) susceptible form
                       ILKEPVHGi Pol(464-472) susceptible form
                       ILKEPVHGV Pol(464-472) A2 human epitope
                       ILKdPVHGV Pol(464-472) observed variant
                       ILKEPVHGV Pol(464-472) A2 supertype human, mouse epitope
                       ILKEPVHGV Pol(464-472) A2 supertype human epitope
                       ILKEPVHGV Pol(464-472) human epitope
                       ILKEPVHGV Pol(464-472) human epitope
                       ILKEPVHGV Pol(464-472) human epitope
                       ILKEPVHGV Pol(464-472) human epitope
                       ILKEPVHGV Pol(464-472) human epitope
                       IKLEPVHGVY Pol(464-473) A*02 human epitope
                       ILKEPVHGVY Pol(464-473) A*02 human epitope
                       ILKEPVHGVY Pol(464-473) A2 human epitope
                       ILKEPVHGVY Pol(464-473) A2 human epitope
                       IKLEPVHGVY Pol(464-473) A*68:02 human epitope
                       IKLEPVHGVY Pol(464-473) B*15 human epitope
                       ILKEPVHGVY Pol(464-473) B*15 human epitope
                       IKLEPVHGVY Pol(464-473) B*15 human epitope
                       IKLEPVHGVY Pol(464-473) B*15 human epitope
                       ILKEPVHGVY Pol(464-473) B15 human epitope
                       ILKEPVHGVY Pol(464-473) B15 human epitope
                       ILKEPVHGVY Pol(464-473) B*15:01 human epitope
                       IKLEPVHGVY Pol(464-473) B*15:01 human epitope
                       IKLEPVHGVY Pol(464-473) B*15:03 human epitope
                       ILKEPVHGVY Pol(464-473) B*15:10 human epitope
                       ILKEPVHGaY Pol(464-473) diminished response; escape documented in this paper; non-susceptible form
                       ILKEtVHGaY Pol(464-473) diminished response; escape documented in this paper; non-susceptible form
                       ILKEsVHGaY Pol(464-473) diminished response; escape documented in this paper; non-susceptible form
                       ILKaPVHGaY Pol(464-473) diminished response; escape documented in this paper; non-susceptible form
                       ILKkPVHGaY Pol(464-473) diminished response; escape documented in this paper; non-susceptible form
                       ILrEPVHGaY Pol(464-473) diminished response; escape documented in this paper; non-susceptible form
                       ILrEPVHGVY Pol(464-473) diminished response; escape documented in this paper; non-susceptible form
                       IKLEPVHGVY Pol(464-473) B*62 human epitope
                       ILKEPVHGVY Pol(464-473) B62 human epitope
                       ILKEPVHGVY Pol(464-473) B62 human epitope
                       IKLEPVHGVY Pol(464-473) B*81 human epitope
                       ILKEPVHGVY Pol(464-473) C*03:03 human epitope
                       ILrEPVHGVY Pol(464-473) escape documented in this paper
                       IKLEPVHGVY Pol(464-473) C*12 human epitope
                       ILKEPVHGVY Pol(464-473) C*12:02 human epitope
                       ILKEPVHGaY Pol(464-473) altered KIR binding or increased/decreased off-rate
                       ILKEPVHGVY Pol(464-473) C*12:02 human epitope
                       ILKEPVHGVY Pol(464-473) C*12:02 human epitope
                       ILKEPVHGaY Pol(464-473) escape documented in this paper; reversion
                       ILKEPVHGVY Pol(464-473) human epitope
                       ILKEPVHGVYY Pol(464-474) B*52:01 human epitope
                       ILrEPVHGVYY Pol(464-474) diminished HLA binding or increased off-rate; observed variant
                       ILKEPVHGVYY Pol(464-474) C*12:02 human epitope
                       ILKEPVHGVYY Pol(464-474) C*12:02 human epitope
                        LKEPVHGV Pol(465-472) human epitope
                        LKEPVHGVY Pol(465-473) human epitope
                        LKDPVHGVYYDPSKD Pol(465-479) human epitope
                        LKDPVHGVYYDPSKD Pol(465-479) human epitope
                         KEPVHGVYY Pol(466-474) human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health